Home » Topics » BioWorld Science

BioWorld Science
RSS

Neuronascent studies NNI-362 in healthy aged volunteers in first-in-human trial

Sep. 17, 2019

Phase III PREVENT trial of Cosentyx in nr-axSpA meets 16-week primary endpoint

Sep. 17, 2019

DSMC recommends continuation of U.S. study of IDCT for degenerative disc disease

Sep. 17, 2019

Acceleron ends development of ACE-083 for facioscapulohumeral muscular dystrophy

Sep. 17, 2019

CARB-X to fund Procarta's development of new class of antibiotics targeting ESKAPE pathogens

Sep. 17, 2019

Edoxaban in atrial fibrillation patients after PCI: Results from ENTRUST-AF PCI

Sep. 17, 2019

Boehringer Ingelheim synthesizes new EGFR mutant inhibitors

Sep. 17, 2019

Newave Pharmaceutical identifies WEE1hu inhibitors

Sep. 17, 2019

DE Shaw Research and Relay Therapeutics describe new PTP-1D inhibitors

Sep. 17, 2019

Sumitomo Dainippon Pharma presents dopamine D1 and D2 receptor antagonists

Sep. 17, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 21, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...